<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">J Addict Med</journal-id><journal-id journal-id-type="iso-abbrev">J Addict Med</journal-id><journal-id journal-id-type="pmc-domain-id">2530</journal-id><journal-id journal-id-type="pmc-domain">hhspa</journal-id><journal-title-group><journal-title>Journal of addiction medicine</journal-title></journal-title-group><issn pub-type="ppub">1932-0620</issn><issn pub-type="epub">1935-3227</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>HHS Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11537837</article-id><article-id pub-id-type="pmcid-ver">PMC11537837.1</article-id><article-id pub-id-type="pmcaid">11537837</article-id><article-id pub-id-type="pmcaiid">11537837</article-id><article-id pub-id-type="manuscript-id">NIHMS2010135</article-id><article-id pub-id-type="pmid">38912696</article-id><article-id pub-id-type="doi">10.1097/ADM.0000000000001337</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2010135</article-id><article-id pub-id-type="manuscript-id-alternative">HHSPA2010135</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Naloxone Use During Pregnancy &#8211; Data from 26 U.S. Jurisdictions, 2019-2020</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Board</surname><given-names initials="A">Amy</given-names></name><degrees>DrPH</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>D&#8217;Angelo</surname><given-names initials="DV">Denise V.</given-names></name><degrees>MPH</degrees><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Miele</surname><given-names initials="K">Kathryn</given-names></name><degrees>MD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Asher</surname><given-names initials="A">Alice</given-names></name><degrees>PhD</degrees><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>von Essen</surname><given-names initials="BS">Beatriz Salvesen</given-names></name><degrees>MPH</degrees><xref rid="A4" ref-type="aff">d</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Denny</surname><given-names initials="CH">Clark H</given-names></name><degrees>PhD</degrees><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Terplan</surname><given-names initials="M">Mishka</given-names></name><degrees>MD</degrees><xref rid="A5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Dunkley</surname><given-names initials="J">Janae</given-names></name><degrees>MPH</degrees><xref rid="A1" ref-type="aff">a</xref><xref rid="A6" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Kim</surname><given-names initials="SY">Shin Y.</given-names></name><degrees>MPH</degrees><xref rid="A1" ref-type="aff">a</xref></contrib></contrib-group><aff id="A1"><label>a</label>Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention</aff><aff id="A2"><label>b</label>Division of Violence Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention</aff><aff id="A3"><label>c</label>Division of Overdose Prevention, National Center for Injury Prevention and Control, Centers for Disease Control and Prevention</aff><aff id="A4"><label>d</label>Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention</aff><aff id="A5"><label>e</label>Friends Research Institute</aff><aff id="A6"><label>f</label>Oak Ridge Institute for Science and Education</aff><author-notes><corresp id="CR1"><label>*</label>Corresponding author: Amy Board, Division of Birth Defects and Infant Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, 4770 Buford Highway MS106-3, Atlanta, GA 30341, <email>ocg3@cdc.gov</email></corresp><fn fn-type="COI-statement" id="FN1"><p id="P19"><bold>Conflicts of Interest:</bold> None.</p></fn></author-notes><pub-date pub-type="ppub"><season>Nov-Dec</season><year>2024</year></pub-date><pub-date pub-type="epub"><day>24</day><month>6</month><year>2024</year></pub-date><volume>18</volume><issue>6</issue><issue-id pub-id-type="pmc-issue-id">474445</issue-id><fpage>711</fpage><lpage>714</lpage><pub-history><event event-type="nihms-submitted"><date><day>24</day><month>07</month><year>2024</year></date></event><event event-type="pmc-release"><date><day>06</day><month>11</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>06</day><month>11</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-11-07 09:25:19.263"><day>07</day><month>11</month><year>2024</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2010135.pdf"/><abstract id="ABS1"><sec id="S1"><title>Objectives:</title><p id="P1">We aimed to determine the prevalence of self-reported naloxone use during pregnancy among people in the U.S. with a recent live birth. A secondary objective was to characterize people at increased risk for overdose who did and did not use naloxone.</p></sec><sec id="S2"><title>Methods:</title><p id="P2">We analyzed data from the Pregnancy Risk Assessment Monitoring System from 26 U.S. jurisdictions that conducted an opioid supplement survey from 2019 through 2020. Respondents with increased risk of experiencing an opioid overdose were identified based on self-reported use of illicit amphetamines, heroin, cocaine, or receiving medication for opioid use disorder (MOUD) during pregnancy. Weighted prevalence estimates and 95% confidence intervals were calculated for reported naloxone use at any point during pregnancy among people with an increased risk of overdose.</p></sec><sec id="S3"><title>Results:</title><p id="P3">Naloxone use during pregnancy was reported by &lt; 1% of the overall study population (unweighted N=88/34,528). Prevalence of naloxone use was 5.0% (95% CI: 0.0-10.6) among respondents who reported illicit amphetamine use, 15.2% (1.8-28.6) among those who reported heroin use, and 17.6% (0.0-38.1) among those who reported cocaine use. Naloxone use was 14.5% (8.4-20.6) among those who reported taking MOUD. Among people with increased risk of overdose, no significant differences in naloxone use were observed by age, race/ethnicity, education level, residential metropolitan status, or insurance status.</p></sec><sec id="S4"><title>Conclusions:</title><p id="P4">Prevalence of naloxone use among people with an increased risk of overdose during pregnancy ranged from 5.0% to 17.6%. Access to naloxone, overdose prevention education, and treatment for substance use disorders may help reduce morbidity and mortality.</p></sec></abstract><kwd-group><kwd>PRAMS</kwd><kwd>naloxone</kwd><kwd>overdose</kwd><kwd>opioid</kwd><kwd>stimulant</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>